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Abstract:  Candidate gene and genome-wide association studies have led to the discovery of nine loci involved in 
Mendelian forms of obesity and 58 loci contributing to polygenic obesity. These loci explain a small fraction of the 
heritability for obesity and many genes remain to be discovered. However, efforts in obesity gene identification greatly 
modified our understanding of this disorder. In this review, we propose an overlook of major lessons learned from 15 
years of research in the field of genetics and obesity. We comment on the existence of the genetic continuum between 
monogenic and polygenic forms of obesity that pinpoints the role of genes involved in the central regulation of food 
intake and genetic predisposition to obesity. We explain how the identification of novel obesity predisposing genes has 
clarified unsuspected biological pathways involved in the control of energy balance that have helped to understand past 
human history and to explore causality in epidemiology. We provide evidence that obesity predisposing genes interact 
with the environment and influence the response to treatment relevant to disease prediction.  
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INTRODUCTION 
  In 2001, six genes were linked to monogenic human 
obesity and no common variants were reproducibly 
associated with polygenic obesity. By 2008, progress in the 
field led to the discovery of eight monogenic genes and four 
polygenic genes (FTO, PCSK1, MC4R, CTNNBL1) from 
associated studies at the genome-wide level of significance. 
The recent emergence of the genome-wide association 
studies (GWAS) has led to further breakthroughs in gene 
identification and now nine loci are recognized to be 
involved in Mendelian forms of obesity along with 58 loci 
contributing to polygenic obesity. In this review, we will 
discuss what we have learned from this recent progress in 
elucidating the molecular basis of obesity. We propose an 
overlook of major lessons learned from 15 years of research 
in the field of the genetics and obesity. 
GENETICS OF OBESITY: LESSONS LEARNED 
A Continuum between Monogenic and Polygenic Obesity 
  A striking observation is the existence of a partially 
overlapping continuum between monogenic and polygenic 
forms of obesity. Currently, four genes (MC4R, PCSK1, 
POMC  and BDNF) have been involved in the two 
conditions, and this list is likely to grow in the upcoming 
years. This continuum is not specific to obesity, since one-
fifth of the loci that were found to be associated with   
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complex disease traits include a gene that is mutated in a 
corresponding single-gene disorder [1]. The case of MC4R is 
illustrative of this point of view. Whereas more than 150 
loss-of-function coding mutations have been associated with 
monogenic obesity [2], two infrequent gain-of-function 
coding polymorphisms (V103I and I251L) have been 
associated with the protection from obesity [3, 4]. 
Furthermore, a SNP located 188 kb downstream of the 
MC4R coding sequence has been associated with a modest 
increase in the risk for obesity [5].  
 Dickson  et al. [6] have recently proposed the synthetic 
association hypothesis: GWAS signals of common non-
functional SNPs outside of coding regions may be the result 
of a combination of rare/coding functional variants with 
stronger effects given that these rare variants arose on a 
haplotype which is tagged by the common SNP. This 
hypothesis, if true, may explain why some genes are 
associated with monogenic and polygenic forms of the same 
disease. A careful investigation of MC4R has therefore 
invalidated the synthetic association hypothesis at this locus, 
and supports the concept of an independent contribution of 
both rare and common variants at the same locus for obesity 
risk [7].  
  Another lesson of the observed continuum between 
monogenic and polygenic forms of obesity is that GWAS-
derived novel loci should be considered as highly relevant 
candidate genes for monogenic obesity, especially if 
additional arguments in humans or animal models strengthen 
the candidacy of the gene. The SH2B1 gene is for instance an 
interesting candidate as SNPs at the SH2B1 locus are 
associated with BMI by GWAS [8], rare deletions including 
SH2B1 are associated with a Mendelian form of obesity [9, 170    Current Genomics, 2011, Vol. 12, No. 3  Choquet and Meyre 
10] and inactivation of SH2B1 in mice leads to hyperphagia, 
leptin resistance and obesity [11]. However, notable 
exceptions have been reported for other promising candidate 
genes. For example, FTO is the major contributor to 
polygenic obesity [12] and mice down or over-expressing 
FTO are resistant or prone to develop obesity [13, 14]. 
However, heterozygous loss-of-function mutations in FTO 
are found in both lean and obese subjects and do not 
contribute to monogenic obesity [15]. 
Obesity is an Inherited Disorder of Central Regulation of 
Food Intake  
  Defects in eight genes involved in the neuronal 
differentiation of the paraventricular nucleus and in the 
leptin/melanocortin pathway, have been shown to lead to 
human monogenic obesity with hyperphagia as a common 
feature [16]. Recent progress in the elucidation of polygenic 
predisposition to obesity also points to a key role of the 
central nervous system in body weight regulation [17].  
  The association of the two major contributors to 
polygenic obesity (SNP rs17782313 near MC4R and SNP 
rs1421085 / rs9939609 in FTO) [5, 18, 19] with food intake / 
food behavior-related endophenotypes has been well 
documented in the literature. The obesity predisposing FTO 
variant was associated with increased total and fat dietary 
intake in children [20, 21] as well as in adults [22]. The 
obesity risk variant was also associated with diminished 
satiety and / or increased feeling of hunger in children [23] 
and in adults [24]. The obesity predisposing SNP variant 
near MC4R was associated with increased feeling of hunger 
[25, 26], increased snacking [25], decreased satiety [26], and 
increased total, fat and protein energy intake [25, 27], the 
effects of the variant on food-related parameters being 
observed both in children and adults. Bauer et al. [28] 
recently reported evidence for an association of additional 
obesity genes recently identified by GWAS (SH2B1, 
KCTD15, MTCH2, NEGR1, BDNF) with dietary intake and 
nutrient-specific food preference.  
  The genetic dissection of monogenic and polygenic 
forms of obesity delineate it as an inherited disorder of 
central regulation of food intake [16]. This is in line with the 
fact that food intake-related parameters are heritable [29] and 
are strongly correlated to body mass index [30].  
Gene Identification Illuminates New Pathways Involved 
in Energy Balance 
  A primary goal of human genetic agnostic approaches 
such as GWAS is to improve our understanding of the 
biologic pathways underlying polygenic diseases and traits 
[1]. A majority of obesity loci identified by GWAS studies 
do not harbor genes with clear connections to the biology of 
body weight regulation [12], reflecting our limited 
understanding of the biology of obesity in contrast with other 
complex traits (such as autoimmune diseases or lipid levels). 
Recent progress in genetic dissection of obesity 
predisposition provides the opportunity to explore novel and 
sometimes unsuspected pathways related to this condition.  
 The  FTO story constitutes a textbook case: the FTO gene 
has been cloned in mice in 1999 [31] but the “buzz” around 
this gene started after the publication of two seminal genetic 
studies demonstrating a link between FTO common gene 
variation and human obesity in 2007 (at this time, FTO was a 
gene of unknown function in an unknown pathway) [18, 19]. 
More than 400 articles have been published since increasing 
our understanding of the mechanisms linking this gene to the 
pathophysiology of obesity. Follow-up studies have 
confirmed the association between FTO and obesity-related 
phenotypes not only in populations of European ancestry but 
also in African, Asian, South Asian, South American and 
Pima Indian populations [32-36].  
  Complete FTO deficiency in humans is associated with 
an autosomal-recessive lethal syndrome including growth 
retardation, multiple malformations and premature death, 
indicating that FTO is essential for normal development of 
the central nervous and cardiovascular systems in human 
[37]. Loss of one functional copy of FTO in humans was not 
associated with a specific phenotype, and heterozygous loss-
of-function mutations are found both in lean and in obese 
subjects [15]. Complete or partial inactivation of the Fto 
gene in mice protects from obesity [13, 38] whereas over-
expression of Fto in mice increases food intake and results in 
obesity [14]. These data have provided direct functional 
evidence that FTO is a causal gene underlying obesity, and 
suggest the intronic variant in FTO may increase obesity risk 
in humans through FTO gain of expression. Expression 
studies in wild-type rodents have shown that FTO is highly 
expressed in the hypothalamus and is regulated by feeding 
and fasting [39, 40]. Over- or down-expression of Fto in the 
hypothalamus modulates food intake in mice possibly 
through the leptin / STAT3 signalling pathway [40, 41].  
 Bioinformatics,  in vitro and crystallography studies have 
shown that FTO is a single-stranded DNA demethylase and 
is involved in nucleic acid repair or modification processes 
[39, 42]. The link between this genes’ ability to modify 
nucleic acids and body weight regulation may be puzzling, 
but may relate to epigenetic processes. FTO has been 
proposed as a transcriptional coactivator that enhances the 
transactivation potential of the CCAAT / enhancer binding 
proteins (C/EBPs) from unmethylated as well as 
methylation-inhibited promoters, suggesting a role in the 
epigenetic regulation of the development and maintenance of 
fat tissue [43]. In line with this hypothesis the fact that the 
FTO intronic SNP is associated with a distinct methylation 
pattern of a 7.7 kb region at the FTO locus, that includes a 
highly conserved non-coding element validated as a long-
range enhancer [44].  
  The study of FTO illustrates how human genetic 
“hypothesis free” approaches can be a catalyst to approaches 
in functional genomics and the same integrative approach 
can be applied to other obesity-associated genes markedly 
increasing our understanding of the physiology of obesity in 
the upcoming years.  
Obesity Genes to Explore Causality in Epidemiology: 
The Mendelian Randomization Approach  
  Spurious associations in observational epidemiological 
studies are commonly caused by confounders due to social, 
behavioral, or environmental factors and can therefore be 
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causation, in which the phenotypic outcome subsequently 
influences an environmental exposure such that it is wrongly 
implicated in the pathogenesis. Genetic epidemiology can be 
used to uncover more thoroughly and more accurately causal 
factors underlying common diseases or complex traits. The 
epidemiologic approach with the most promise is often 
referred to as Mendelian randomization [45]. The principle is 
to use genetic variation as a randomly redistributed variable 
among populations to control for unobserved confounding 
variables in an observational setting [45].  
  This approach has been successfully used in the obesity 
arena following the identification of FTO as a major 
contributor to polygenic variation [18]. The Frayling et al. 
[18] seminal study represents in fact a good example of 
Mendelian randomization since a BMI-dependent 
association between FTO and type 2 diabetes mellitus (T2D) 
has been observed, suggestive of a causative relationship 
between weight gain and subsequent T2D development. The 
same approach, when applied to 12 obesity gene variants, 
confirmed that the genetic predisposition to obesity leads to 
an increased risk of developing type 2 diabetes, which is 
completely mediated by its effect on BMI [46]. The FTO 
genotype has also been used to confirm the findings of 
observational epidemiology and a causal relationship 
between BMI increase and altered glucose [47], insulin 
resistance [48], lipid [47] and blood pressure values [49]. 
The causal association between increased BMI and increased 
level of inflammation [50] or increased bone mass [51] has 
also been confirmed, and the use of FTO SNP as a randomly 
redistributed variable strengthened the evidence of a causal 
link between a BMI increase and an increased risk of 
atherosclerosis [52], cardiovascular diseases [53], 
endometrial or kidney cancers [54, 55] and a decreased risk 
of lung or prostate cancers [54, 56].  
Genes are Useful to Understand Past Human History 
  The human genome contains hundreds of regions whose 
pattern of genetic diversity indicate recent positive natural 
selection (positive natural selection is the force that drives 
the increase in prevalence of advantageous traits like de novo 
mutations) [57]. Adaptation to new environments, infectious 
diseases and changes in diet may explain why certain 
mutations have been positively selected in human 
populations [58]. The transition to agriculture has introduced 
new adaptive pressures that shaped our genome to an 
increased fat storage efficiency including exposure to regular 
famine, adaptation to a variety of local niches favoring 
population-specific adaptations and the development of 
social hierarchies which predispose to differential exposure 
to environmental pressures [59]. The “thrifty genotype” 
hypothesis, proposed by Neel in 1962 [60], was recently 
confirmed for several obesity genes that show evidence of 
positive selection across human history. For example, the 
rs4988235 functional variant in the lactase (LCT) gene 
confers lactase persistence and carriers of at least one T 
allele, are able to digest the milk sugar lactose across their 
life span (the activity of the lactase enzyme in intestinal cells 
declines during childhood in non-carriers) [61, 62]. The 
selective advantage of lactase persistence in milk-producing 
dairy farming populations has induced positive selection 
signatures regionally for the LCT rs4988235 T variant 
strongly related to events of cattle domestication [63, 64]. A 
North to South gradient has been observed for the LCT 
rs4988235 SNP in Europe [63] as well as local geographic 
population substructures among provinces in the United 
Kingdom [65]. In line with its proposed selective advantage, 
the  LCT rs4988235 T variant has been consistently 
associated with higher milk consumption [66] and with 
higher body mass index [67] in European populations. 
  Interestingly, three functional coding non-synonymous 
variants in the LEPR (Lys109Arg), ADRB3 (Trp64Arg) and 
BDNF (Val66Met) genes previously associated with BMI [8, 
68, 69], harbor patterns of strong positive selection in 
population genetic studies [70-72]. Recently, analysis of 
GWAS-derived obesity gene variants provided evidence of 
positive natural selection at the FTO, NEGR1, SH2B1 and 
FAIM2 loci [73, 74].  
  The evolutionary history of the MC4R obesity locus has 
been well documented in the literature. The melanocortin 4 
receptor coding sequence has been remarkably conserved in 
structure and pharmacology for more than 400 million years, 
implying that this receptor participated in vital physiological 
functions early in vertebrate evolution [75]. There is a 
significant paucity of diversity at the MC4R gene in humans 
in comparison with primates [76]. The coding region of 
MC4R has been subject to high levels of continuous 
purifying selection that increased threefold during primate 
evolution [76]. Finally, there is a tendency for non-
synonymous mutations that impact MC4R function to be 
located at amino acid positions that are highly conserved 
during the 450 million years of MC4R evolution in 
vertebrates and subject to very strong purifying selection 
[76]. 
Genes Interacting with Environments  
  As trends over the past several decades suggest an 
environmental influence on BMI, many researchers have 
focused on the identification of specific environmental 
factors that interact with genetic predisposition to obesity. 
They based their investigations on epidemiological data 
showing that physical activity, diet, educational status, age, 
gender and ethnicity among others modulate the risk for 
obesity [77].  
  Recent literature provides firm evidence that genetic 
susceptibility to obesity can be blunted in part through 
physical activity. Thirteen independent studies reported an 
interaction between the FTO obesity risk genotype and 
physical activity on BMI variation or obesity risk including 
adults as well as adolescents [78-81]. Similar results were 
obtained for a genetic predisposition score combining the 
information of 12 obesity-associated SNPs, and a high level 
of physical activity associated with a 40% reduction in the 
genetic predisposition to common obesity [82].  
  There is also growing evidence that dietary habits 
interact with genes to modulate predisposition to obesity. 
Three studies suggest that a high fat diet can amplify the 
effect of the FTO genotype on obesity risk [79-81]. An 
interaction between the Apolipoprotein A-II (APOA2) -
265T>C SNP and high-saturated fat in relation to BMI and 
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[83, 84]. Interestingly, this SNP was not identified by recent 
GWAS approaches, suggesting that some associations 
restricted to specific environments may be missed in global 
analyses.  
  Epidemiological studies have shown that people with a 
low level of education are more likely to develop obesity 
[85]. However, very few studies have investigated the impact 
of genes on the association between education and obesity-
related variables. This well-established negative association 
between BMI and educational status was not found in MC4R 
loss-of function mutation carriers, although a significant 
relationship was seen in MC4R non-mutation carriers of the 
corresponding pedigrees [2]. These results suggest that a 
high level of education has no protective effect on obesity 
risk in presence of MC4R pathogenic mutations. On the 
contrary, a significant gene x education interaction has been 
found for the intron 1 variant in FTO, the significant effect 
of the SNP on BMI and obesity risk being restricted to 
subjects with no university education [86].  
  Age-dependent genetic associations have been described 
both in the context of monogenic and polygenic obesity. An 
age-dependent penetrance of MC4R pathogenic and 
monogenic mutations on obesity has been found in 
multigenerational pedigrees, the effect of mutations on the 
obesity phenotype being amplified by the development of an 
"obesogenic" environment [2]. The longitudinal study of 
adult  MC4R mutation carriers showed an increasing age-
dependent penetrance (37% at 20 years versus 60% at >40 
years) [2]. The life-course analysis of the intronic FTO gene 
variant and body mass index in independent longitudinal 
studies indicates that most of the effect of the SNP on BMI 
gain occurs during childhood, adolescence and young 
adulthood [87-89].  
  Gender can be assimilated as a specific environmental 
condition. Females are at higher risk of developing morbid 
obesity than males [90]. These discrepancies could be 
explained in part by female-specific genetic associations or 
by stronger effect sizes of genetic variants in females. This 
was observed for the carriers of MC4R pathogenic 
monogenic mutations since BMI was about twice as strong 
in females than in males [2, 91]. The effect of the functional 
polymorphism R125W polymorphism in TBC1 domain 
family member 1 (TBC1D1) gene on severe obesity risk was 
restricted to females in French and US populations [92, 93]. 
Seven out of 14 loci convincingly associated with waist to 
hip ratio exhibited marked sexual dimorphism, all with a 
stronger effect on the phenotype in women than men [94, 
95]. 
  Ethnicity can be considered as an environmental factor 
that affects the genetic susceptibility to obesity. A 
convincing example of ethnic-specific association with 
obesity has been reported for the SIM1 gene. Variants in 
intronic regions of SIM1 were strongly associated with BMI 
and obesity risk (P = 4 x 10
-7) in Pima Indians contrarily to 
French Europeans for which a major contribution of SIM1 
common variants in polygenic obesity susceptibility was 
excluded [96, 97]. A functional coding variant (W64R) [98] 
in the ADRB3 gene has also been convincingly associated 
with BMI in East Asian but not in European subjects in a 
large meta-analysis of 44,833 subjects [69], the effect of the 
R64 allele on BMI increase being four-fold higher in Asian 
than in European subjects. More recently, a SNP 
(rs2074356) in the 24
th intron of the C12orf51 transcript has 
been strongly associated with waist to hip ratio (P = 7.8 x 10
-12) 
in the Korean population [99]. This variant has not been 
identified in a large GWAS meta-analysis for waist to hip 
ratio conducted in 77,167 individuals of European ancestry 
[95], suggesting an ethnic-specific association at this locus. 
These studies highlight the complex interplay between 
genetic susceptibility to obesity and environment.  
Genes Influencing Response to Treatment 
  To date, three main therapeutic options are proposed to 
treat obesity: lifestyle intervention, pharmacotherapy and 
bariatric surgery. The aim of these therapeutics for obesity 
are to lose weight and maintain this weight-loss on the long 
term and attenuate co-morbidities related to obesity. There is 
growing evidence that genetic factors not only predispose to 
weight gain and development of obesity, but also modulate 
the response to therapeutic intervention in terms of weight 
loss. 
Lifestyle Modifications 
 Individuals  with MC4R or POMC monogenic conditions 
respond well to hypocaloric dietary or multidisciplinary 
(exercise, behavior, nutrition therapy) interventions as do 
non-monogenic obese subjects [100, 101] but MC4R 
individuals fail to maintain weight loss after intervention 
[101]. The major gene variant contributing to polygenic 
obesity  FTO does not modify the response to lifestyle 
intervention in terms of weight loss [102], but may interact 
with specific components of the lifestyle intervention 
program like the type of diet proposed during the caloric 
restriction program (high-fat, low-fat, Mediterranean diets) 
[103, 104] or with physical activity [105] to modulate weight 
loss.  
Pharmacotherapy 
  To date, only one successful personalized medicine 
approach which is based on a genetic diagnosis has been 
reported in the literature in the context of obesity: 
individuals with congenital leptin deficiency can be treated 
with daily injections of recombinant human leptin, which 
reverses the obesity and associated phenotypic abnormalities 
[106]. Leptin administration dramatically reduces food 
intake, fat mass, hyperinsulinemia, and hyperlipidemia, 
restores normal pubertal development, endocrine and 
immune function and increases performances in many 
neurocognitive domains [107]. Individuals with complete 
leptin deficiency are extremely rare (14 are reported so far 
worldwide) but peripheral leptin supplementation may also 
be extended to a numerically significant group of obese 
subjects with partial leptin deficiency, on the observation 
that peripheral leptin supplementation induces significant 
weight loss in those with low levels of leptin [108]. In 
addition, chemical chaperones and pharmacological agonists 
efficiently restore cell surface expression and endogenous 
agonist response of mutated melanocortin 4 receptors [109, 
110], but in vivo beneficial effects in MC4R deficient 
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  To date, the two main anti-obesity drugs used are orlistat 
and sibutramine (a saturated derivative of lipstatin and a 
serotonin-norepinephrine reuptake inhibitor, respectively). 
The guanine nucleotide binding protein beta polypeptide 3 
(GNB3) gene C825T polymorphism is highly predictive for 
the identification of obese individuals who will benefit from 
sibutramine treatment. Thus, three independent 
pharmacogenetic studies have shown an association between 
the GNB3 C825T polymorphism and weight loss induced by 
sibutramine [111-113]. Interestingly, this locus has not been 
identified by recent GWAS on obesity-related traits, 
suggesting that the genes associated with BMI variation and 
obesity risk may be at least partly different from genes 
involved in therapeutic response in terms of weight loss.  
Bariatric Surgery 
  Bariatric surgery is the most effective long-term 
treatment for severe obesity, reducing obesity-associated co-
morbidities but the mechanisms of weight loss after bariatric 
surgery and the role of central energy homeostatic pathways 
in this weight loss process are not well understood. Two 
recent studies assessed the response to bariatric surgery of 
MC4R monogenic mutation carriers [114, 115]. The Roux-
en-Y gastric bypass surgery was associated with a similar 
percentage of excess weight loss in four heterozygous MC4R 
mutation carriers and in matched MC4R mutation non-carrier 
obese controls [115]. On the contrary, an adolescent with 
complete MC4R deficiency underwent laparoscopic 
adjustable gastric banding at 18 years of age which resulted 
in an initial, but not long-term weight loss [114]. These 
preliminary results need to be confirmed in larger studies, 
but logically suggest that diversionary operations, which are 
more invasive, efficiently improve the neuro-hormonal 
control of satiety better than gastric banding procedures, and 
are therefore indicated in monogenic hyperphagic subjects.  
  In the Swedish obesity intervention study, the FTO 
obesity predisposing allele carriers lost 3kg less than 
common allele homozygotes after obesity surgery, and this 
association was restricted to those undergoing banding 
surgery but was not significant in the gastric bypass operated 
subjects [116]. In a cohort of 1,001 severely obese subjects 
who underwent gastric bypass surgery, an allelic risk score 
combining the genetic information of four obesity-associated 
SNPs was significantly associated with postoperative weight 
loss trajectories [117]. Thus, obesity predisposing genes 
modulate the response to therapeutic options in terms of 
weight loss suggesting that genetic diagnosis combined with 
a genomic personalized medicine approach is a plausible 
strategy in order to design and implement the most suitable 
treatment and to achieve higher rates of therapeutic success. 
Obesity Genes and Disease Prediction 
  Traditional approaches for the management of 
overweight and obesity have proven poor long term efficacy 
and obesity surgery is an efficient but invasive procedure. 
Prevention may therefore be considered as a promising 
strategy to face the obesity epidemic. In that context, the use 
of genetic information in clinical practice to predict 
individuals at high risk early in life and before the 
development of the disease remains the 'Holy Grail' for many 
geneticists [118]. Is the current knowledge about obesity 
genetics, sufficient to envisage such translational medicine 
applications?  
Common Genetic Variants: Still Few Informative  
  GWAS allowed the identification of 36 polymorphisms 
robustly associated with BMI. However, identified variants 
have small effect sizes and collectively explain 1.45% of the 
variance in BMI (0.34% explained by the SNP in intron 1 of 
FTO alone) [12]. Therefore, it is not surprising that the 
combined information of 12-20 obesity predisposing SNPs 
provides only a slight increase in the ability to predict 
obesity in comparison with conventional nongenetic risk 
factors and has no clinical utility [119]. Risk prediction using 
GWAS remain conceivable despite the fact that individual 
effect sizes of variants associated with the phenotype are 
mostly small. In fact, it seems that many disease-associated 
variants are not yet identified prospects for risk prediction, 
but may improve if more disease predisposing variants are 
included in the models [120]. New iterative algorithms have 
been recently proposed to make better use of the whole-
genome SNP information to improve the performance of 
disease risk assessment by utilizing a larger number of SNPs 
than those which reach genome-wide significance [120, 
121].  
Monogenic Genes may Explain a Non-Negligible Fraction 
of Obesity  
  The cumulative prevalence of monogenic obesity 
elucidated by the eight currently known genes and the 
16p11.2 deletion has not been evaluated in a randomly 
ascertained cohort of obese subjects to date, but may be 
estimated between 5 and 10 %. These results re-emphasize 
the importance of monogenic obesity in elucidating the 
heritability of obesity, and Mendelian forms of obesity may 
provide a non-negligible predictive value in classifying 
young subjects at high risk for the development of childhood 
obesity, as deleterious coding mutations or chromosomal 
aberrations in these genes / regions induce highly penetrant 
forms of obesity. Subjects carrying these mutations, present 
specific features according to the impaired gene (such as a 
low level of circulating leptin despite severe obesity, a 
susceptibility to infections, intestinal dysfunction, reactive 
hypoglycaemia, red hair and pale skin, adrenal insufficiency) 
that can guide gene sequencing approaches. Early diagnosis 
is fundamental for personalized prevention and effective 
therapeutic management, and in young non-obese 
individuals carrying MC4R monogenic mutations, an 
appropriate medical follow-up to prevent or at least delay the 
onset of obesity [122]. 
  As hyperphagia is a common feature of monogenic 
obesity, the most effective preventive strategy may be 
stringent restriction of food access. This will require training 
and active participation of the parents and care providers and 
the identification of critical environmental components 
(physical activity, rural / urban environment, dietary profile, 
family structure, socioeconomic status, social network, 
psychosocial stress) that modulate the penetrance of obesity 
associated with pathogenic mutations in order to avoid 
unhealthy environments for these subjects.  
  In conclusion, we have demonstrated that 15 years of 
gene identification efforts have considerably modified our 174    Current Genomics, 2011, Vol. 12, No. 3  Choquet and Meyre 
understanding of the biology of obesity. Promising 
approaches such as whole-exome and ultimately whole-
genome sequencing have the potential to lead to an 
exhaustive map of obesity predisposing genes in the near 
future. Recent gene identification efforts have provided a 
more comprehensive picture of the biological mechanisms 
involved in the development of obesity and we feel that this 
information can be meaningful not only for scientists and 
clinicians but for a more general audience. For instance, the 
recent discoveries in genetics have found that people differ 
in their perceptions of hunger and satiety on a genetic basis 
and that predisposed subgroups of the population may be 
particularly vulnerable to obesity in “obesogenic” societies 
with unlimited access to food. This notion must lead to a 
more open attitude toward obese people and a reduction in 
discrimination against them [123], it is clear that obesity 
cannot be considered as a consequence only of indolence or 
lack of will, as often thought in our societies. In the long 
term, we are confident that progress in genetics will help to 
develop useful diagnostic and predictive tests and design 
new treatments.  
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